PH18968A - Method for allevitaion of extrapyramidal motor disorders - Google Patents

Method for allevitaion of extrapyramidal motor disorders

Info

Publication number
PH18968A
PH18968A PH30027A PH30027A PH18968A PH 18968 A PH18968 A PH 18968A PH 30027 A PH30027 A PH 30027A PH 30027 A PH30027 A PH 30027A PH 18968 A PH18968 A PH 18968A
Authority
PH
Philippines
Prior art keywords
allevitaion
motor disorders
extrapyramidal motor
extrapyramidal
disorders
Prior art date
Application number
PH30027A
Other languages
English (en)
Inventor
Lloyd E Allen
Leslie A Riblet
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of PH18968A publication Critical patent/PH18968A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH30027A 1982-12-23 1983-12-23 Method for allevitaion of extrapyramidal motor disorders PH18968A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/452,686 US4438119A (en) 1982-12-23 1982-12-23 Method for alleviation of extrapyramidal motor disorders

Publications (1)

Publication Number Publication Date
PH18968A true PH18968A (en) 1985-11-26

Family

ID=23797489

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30027A PH18968A (en) 1982-12-23 1983-12-23 Method for allevitaion of extrapyramidal motor disorders

Country Status (7)

Country Link
US (1) US4438119A (enExample)
JP (1) JPS59130215A (enExample)
AU (1) AU556112B2 (enExample)
BE (1) BE898540A (enExample)
DE (1) DE3346237A1 (enExample)
PH (1) PH18968A (enExample)
ZA (1) ZA839451B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634703A (en) * 1985-10-25 1987-01-06 Bristol-Myers Company Method for alleviation of panic disorders
US4640921A (en) * 1986-02-04 1987-02-03 Bristol-Myers Treatment of sexual dysfunction with buspirone
US4687772A (en) * 1986-10-07 1987-08-18 Bristol-Myers Company Method for improvement of short term memory
US4777173A (en) * 1987-03-25 1988-10-11 Bristol-Myers Company Method for treatment of alcohol abuse
DE3736974A1 (de) * 1987-10-31 1989-05-11 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten
US5468749A (en) * 1988-08-30 1995-11-21 Gawin; Frank H. Method for treatment of substance addiction
US6432956B1 (en) 1990-02-12 2002-08-13 William C. Dement Method for treatment of sleep apneas
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5824680A (en) * 1991-08-31 1998-10-20 Bayer Aktiengesellschaft Ipsapirone for the treatment of alzheimer's disease by improving memory
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
UA73981C2 (en) * 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
EP1408964B1 (en) * 2001-07-26 2007-01-24 MERCK PATENT GmbH Use of 2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl|-chromane and its physiologically acceptable salts
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
GT200600414A (es) * 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
GT200600416A (es) * 2005-09-12 2007-09-20 Sales salicilato y gentisato de un compuesto de piperazina
PE20070523A1 (es) * 2005-09-12 2007-06-28 Wyeth Corp Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona
HRP20161402T1 (hr) * 2010-10-15 2016-12-30 Contera Pharma Aps Kombinacije agonista serotoninskih receptora za liječenje poremećaja kretanja
ES2654787T3 (es) 2012-04-18 2018-02-15 Contera Pharma Aps Formulación farmacéutica disponible por vía oral adecuada para la gestión mejorada de trastornos del movimiento
HUE039750T2 (hu) * 2014-06-26 2019-02-28 Contera Pharma Aps Hidroxi-buspiron mozgászavarok kezelésére
WO2018011181A1 (en) 2016-07-11 2018-01-18 Contera Pharma Aps Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method

Also Published As

Publication number Publication date
US4438119A (en) 1984-03-20
BE898540A (fr) 1984-06-22
AU556112B2 (en) 1986-10-23
ZA839451B (en) 1984-09-26
JPH0422889B2 (enExample) 1992-04-20
DE3346237A1 (de) 1984-07-05
JPS59130215A (ja) 1984-07-26
AU2279383A (en) 1984-06-28

Similar Documents

Publication Publication Date Title
PH18968A (en) Method for allevitaion of extrapyramidal motor disorders
ZA834243B (en) Method for making partially separated multibags
EP0140386A3 (en) Method for the purification of lpf-ha
GB8332072D0 (en) Currency-dispensing method
HUT35000A (en) Process for prodiction of grf-analoges
GB2119808B (en) Method for making methylchlorosilanes
DE3363537D1 (en) Method for the surveyance of an object space
DE3361137D1 (en) Method for the preparation of 3-alkoxy-acrylonitriles
YU237183A (en) Process for obtaining new spiro-3-hetero azolines
GB2134482B (en) Apparatus for self-elevation of vehicles
GB8329676D0 (en) Travelling-wire edm method
IL70220A0 (en) Process for 1-oxa-beta-lactams
YU224786A (en) Process for obtaining of indolylalkyl-aminopropanole
DE3368683D1 (en) Method for performing rate assays
GB2143851B (en) Method for making steel
DE3360001D1 (en) Method for the preparation of 1-alkenylisocyanates
GB2120787B (en) Method of estimating feed additives
BG46665A1 (en) Method for preparing of steroidic suspensions
SU1090406A1 (en) Method of separating alpha-2-macroglobuline
YU183883A (en) Process for fat-separation
BG33808A1 (en) Method for making of poly- delta- valerolactone
BG46375A1 (en) Method for preparing of 11 beta- hydroxysteroides
BG33699A1 (en) Method for heaxchange
HUT34827A (en) Method for meassuring the settling characteristics of sunpensions
BG33490A1 (en) Method for producing of polyetheleneglycols